Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders
Keyword(s):
Keyword(s):
2009 ◽
pp. 156-165
Keyword(s):
Keyword(s):
2014 ◽
Vol 171
(6)
◽
pp. 1289-1290
◽
Keyword(s):
2020 ◽
Vol 100
(7)
◽
pp. adv00095-185
◽
Keyword(s):
2021 ◽
Vol 141
(1)
◽
pp. 72-83.e6
◽